Click Here To View
Latest Diabetes Health Articles
Popular Diabetes Health Articles
Highly Recommended Diabetes Health Articles
Send a link to this page to your friends and colleagues.
Share Your NovoLog® (insulin aspart [rDNA origin] injection) Community Star Story for the Chance to Win a Donation to the Charity of Your Choice!
Novo Nordisk, a world leader in diabetes care, is continuing the search for the first NovoLog® Community Stars. If you haven't submitted yet, entries will be accepted through March 15. Patients with type 2 diabetes who are managing their blood sugar with NovoLog® (insulin aspart [rDNA origin] injection) are invited to visit www.novolog.com and share how they're giving back to their local communities.*
Finalists will each receive a $5,000 donation to a local diabetes-related organization of their choice. One ultimate NovoLog® Community Star will also receive a one-year online subscription to Weight Watchers® to help with their diabetes management.
Weight Watchers® is a registered trademark of Weight Watchers International, Inc.
About NovoLog® (insulin aspart [rDNA origin] injection)
Indications and Usage
What is NovoLog® (insulin aspart [rDNA origin] injection)?
Important Safety Information
Who should not use NovoLog®?
What should I tell my healthcare provider before taking NovoLog®?
How should I take NovoLog® (insulin aspart [rDNA origin] injection)?
What should I consider while using NovoLog®?
Be careful when driving a car or operating machinery. You may have difficulty concentrating or reacting if you have low blood sugar. Talk to your healthcare provider if you often have low blood sugar or no warning signs of low blood sugar. What are the possible side effects of NovoLog®?
NovoLog® is a registered trademark of Novo Nordisk A/S.
Please visit novolog.com for Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
NovoLog® is a prescription medication.
*Certain restrictions apply. See official rules for entry information.
© 2013 Novo Nordisk All rights reserved. 0113-00013265-1 February 2013